Edition:
India

People: Biomarin Pharmaceutical Inc (BMRN.OQ)

BMRN.OQ on NASDAQ Stock Exchange Global Select Market

75.04USD
15 Nov 2019
Change (% chg)

$-0.54 (-0.71%)
Prev Close
$75.58
Open
$76.00
Day's High
$76.00
Day's Low
$74.40
Volume
593,360
Avg. Vol
452,994
52-wk High
$100.13
52-wk Low
$62.89

Baffi, Robert 

Dr. Robert A. Baffi, Ph.D., serves as an Executive Vice President - Technical Operations of Biomarin Pharmaceutical Inc. He joined BioMarin in May 2000 and currently serves as our Executive Vice President of Technical Operations, responsible for overseeing our manufacturing, process development, quality, and analytical chemistry departments. From 2000 to December 2009, Dr. Baffi served as our Senior Vice President of Technical Operations. From 1986 to 2000, Dr. Baffi served in a number of increasingly responsible positions at Genentech, Inc., primarily in the functional area of quality control. Prior to Genentech, Dr. Baffi worked for Cooper BioMedical as a Research Scientist and at Becton Dickinson Research Center as a Post-Doctoral Fellow. Dr. Baffi has contributed to more than 20 regulatory submissions for product approval in the United States and Europe and to more than 50 regulatory submissions for investigational new drug testing. He currently serves on the board for the National Institute for Bioprocessing Research & Training. Dr. Baffi received a Ph.D., M. Phil and a B.S. in biochemistry from the City University of New York and an M.B.A. from Regis University.

Basic Compensation

Total Annual Compensation, USD 524,231
Restricted Stock Award, USD 2,075,350
Long-Term Incentive Plans, USD --
All Other, USD 1,873,650
Fiscal Year Total, USD 4,473,230

Options Compensation

  Quantity Market Value
Exercisable 359,284 273,637.00
Unexercisable 208,959 577,314.00
Exercised 14,051 1,394,730.00
Name Fiscal Year Total

Jean-Jacques Bienaime

15,917,000

Daniel Spiegelman

4,641,880

Henry Fuchs

7,045,420

G. Eric Davis

2,708,210

Jeff Ajer

4,568,300

Robert Baffi

4,473,230
As Of  31 Dec 2017